-
CDEX Inc. Commences Debt Restructuring to Strengthen Company’s Future Competitiveness
Will Continue to Operate Without Interruption TUCSON, AZ--(Marketwire - Feb 10, 2012) - CDEX Inc. (OTCBB: CEXI) today announced that to achieve a debt structure that would allow the Company to continue to develop its leading edge products in the healthcare markets with the ValiMed G4 ...
-
CDEX Appoints Dr. Jason B. Terrell as Medical Director
TUCSON, AZ--(Marketwire - Jan 26, 2012) - CDEX Inc. (OTCBB: CEXI), a leading developer of chemical detection products using patented technologies for use in healthcare, safety and security markets, today announced the appointment of Jason Bradley Terrell, M.D. as medical director of the company. Dr. ...
-
CDEX to Showcase ID2 Line and ValiMed™ G4 System at the ACA – 2012 Winter Conference
TUCSON, AZ--(Marketwire - Jan 18, 2012) - CDEX Inc. (OTCBB: CEXI), a leading developer of chemical detection products using patented technologies for use in healthcare, safety and security markets, to showcase the ID2 Meth Scanner, Pocket ID2 illicit drug detector and the ValiMed™ G4 (VG4) ...
-
Crimetrackers: Hidden threat
TUCSON - When inmates are booked into the Pima County jail just what are they trying to sneak in? Video surveillance provided by the Pima County jail shows a woman reaching into her sock, pulling out crystal meth and then putting it in her mouth attempting ...
-
Jury Awards $12.6M in Teen’s Vaccine Error
The Associated Press Published: Sunday, January 15, 2012 at 8:45 a.m. MIAMI | A teenager who lost all four limbs because of a vaccination error has won a $12.6 million award in a lawsuit against the University of Miami medical school. The Miami jury reached the verdict Friday ...
-
CDEX Inc KUSI TV Special Chemicals Detection Innovations
-
CDEX Showcases the ValiMed™ G4 at the 46th ASHP Conference
VG4 System Features Multi-Compound Measurement and Validation TUCSON, AZ--(Marketwire - Dec 6, 2011) - CDEX Inc. (OTCBB: CEXI), a leading developer of chemical detection products using patented technologies for use in healthcare, safety and security markets, today demonstrated its recently launched ValiMed™ G4 multi-component medication and ...
-
CDEX Ships ValiMed G4 Medication Validation System
Prominent Global Medical Technology Company to Use for Research and Development TUCSON, AZ--(Marketwire - Oct 3, 2011) - CDEX Inc. (OTCBB: CEXI), a leading developer of chemical detection products, using patented technologies for use in healthcare, safety and security markets, announced today the company has shipped ...
-
CDEX to Attend Health Connect Partners 2011 Fall Hospital Pharmacy Conference
ValiMed G4 Medication Validation System Demonstrated at Event TUCSON, AZ--(Marketwire - Sep 27, 2011) - CDEX Inc. (OTCBB: CEXI), a leading developer of chemical detection products, using patented technologies for use in healthcare, safety and security markets, will demonstrate the capabilities of the ValiMed™ G4 drug ...
-
CDEX Reports Third Quarter 2011 Financial Results
Valimed G4 Medication Validation System Launch Expected 4Q 2011 TUCSON, AZ--(Marketwire - Sep 16, 2011) - CDEX Inc. (OTCBB: CEXI), a leading developer of chemical detection products, using its patented technologies, for use in healthcare and security markets, today reported financial results for the third quarter ...

